⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

IDEXX Laboratories maintained a stable risk disclosure framework with 21 unchanged risk factors and no new or removed risk categories between 2024 and 2025. Three risk factors underwent substantive modifications, including updated language on public health pandemic risks, cybersecurity and IT system dependencies, and compliance requirements. The company's overall risk structure remained consistent, suggesting no fundamental shifts in its principal business exposures or operating environment.

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

🟡 Modified We are subject to risks associated with public health issues, including pandemics, which could have a material adverse effect on our financial condition and results of operations 🔒

🟡 Modified We depend on the continuous and reliable operation and security of our information technology systems and our products and services that incorporate or rely on information technology, and any disruption or significant cybersecurity breach or other incident could adversely affect our business 🔒

🟡 Modified Failure to meet current or evolving environmental, social, and governance regulations, standards, or expectations or to achieve our environmental, social, or governance goals could adversely affect our business, results of operations, financial condition, reputation, or stock price 🔒

3 changes in this historical filing

Historical year-over-year comparisons (2025 vs 2024 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →